Insights

In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.

A healthcare clinician reviewing data on a tablet next to a doctor graphic, representing decentralised clinical trials pharma strategy.

Decentralised Clinical Trials Clinical Trial Regulation Clinical Trial Strategy

The Future for Decentralised Clinical Trials

Nicole Dale

AI Drug Discovery Drug Discovery Preclinical Development

Reimagine AI-driven Drug Discovery with Pharmaceutical Superintelligence

Nicole Dale

A blue graphic featuring an upward-trending bar chart and line graph, representing digital health funding Q1 2026, set against a background of close-up medicine pills.

Tech and Innovation AI Drug Discovery AI Drug Development

First Quarter 2026 State of Digital Health Funding

Nicole Dale

Quality-by-Design pharmaceutical innovation in action, featuring tablet formulation analysis, molecular modelling, and digital quality systems supporting efficient drug development and manufacturing.

Maximise Pharma Innovation With Quality-by-Design

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Phenotypic Drug Discovery: Beyond the Target

The Looming Threat of Geopolitical Risk in Clinical Supply Chains

Topic

Therapeutic Drug Discovery
Clinical Development
HealthTech & AI
Technical Operations

Tags

Adaptive Clinical Trials
AI & Machine Learning
AI and Automation
AI Drug Development
AI Drug Discovery
AI in Clinical Trials
Artificial Intelligence in Healthcare
Biologics
Biomedical R&D
Biostatistics
Biotech
Cell and Gene Therapy
Clinical Data
Clinical Logistics
Clinical Outcomes
Clinical Trial Design
Clinical Trial Regulation
Clinical Trial Strategy
CMC
Cold Chain
Continuous Manufacturing
Data and Digital Health
Decentralised Clinical Trials
Decentralised Manufacturing
Diagnostics
Digital Health
Drug Delivery
Drug Discovery
Drug Production
Electronic Data Capture
Generics
Healthcare Technology
HTA and Reimbursement
HTS and Automation
Immunology and Immunotherapy
Infectious Diseases and Vaccines
Investment and Market Analysis
Labelling and Packaging
Medical Devices
Medical Imaging
Medtech
Multiomics
Neurological Disease
Next-gen Modalities
Oncology
Orphan Drugs
Patient Centricity and Outcomes
Patient Enrolment
Pharma Intelligence
Pharma Policy
Pharma Regulation
Pharma Supply Chains
Pharmaceutical Compliance
Pharmaceutical R&D
Pharmacology
Pharmacovigilance
Post-market
Precision Medicine
Preclinical Development
Pricing and Market Access
Quality
Rare Diseases
Remote Clinical Monitoring
Remote Monitoring
RWE Strategy
Small Molecules
Sterile Manufacturing
Tech and Innovation
Telemedicine
Translational Science and Biomarkers
Wearables

Cell Therapy for Solid Tumours: Current Challenges and New Advances

Precision Logistics to Speed Up Clinical Trials

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Maximise Pharma Innovation With Quality-by-Design

Reimagine AI-driven Drug Discovery with Pharmaceutical Superintelligence

Insights

The Future for Decentralised Clinical Trials

Reimagine AI-driven Drug Discovery with Pharmaceutical Superintelligence

First Quarter 2026 State of Digital Health Funding

Maximise Pharma Innovation With Quality-by-Design

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Phenotypic Drug Discovery: Beyond the Target

The Looming Threat of Geopolitical Risk in Clinical Supply Chains